A large-scale real-world study in the USA has reinforced the effectiveness of Beyfortus (nirsevimab-alip), the respiratory ...

Health and Human Services Secretary Robert F. Kennedy Jr. ordered that thimerosal, a mercury-based preservative, be removed from US flu shots based on a recommendation from an influential vaccine ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company has a strong ...

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

ACIP voted to recommend against anyone — adult, child and pregnant person — receiving a seasonal flu vaccine with the mercury-containing compound thimerosal.

CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.

Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more CDC advisory panel, selected by RFK Jr., recommends thimerosal be dropped from flu vaccines ...

(NewsNation) — Health and Human Services Secretary Robert F. Kennedy Jr.’s vaccine committee on Thursday voted to recommend a shot that protects babies against RSV, reports said. The shot ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.